Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Already a subscriber?
Embattled pathology group Healius has stepped up internal restructuring and cost-cutting in a push to lift its financial performance as investment bankers UBS oversee a strategic review.
Two top executives in the groups Queensland pathology business QML have departed in the restructure outlined in an internal email on March 27 from the boss of the Healius Pathology division, Jan Van Rooyen.
The pathology business is the largest division of Healius, which runs 2000 collection centres and 100 testing labs. Getty Images
Mr Van Rooyen was brought in f…
Read the full article at: https://www.afr.com/companies/healthcare-and-fitness/healius-in-management-shake-up-after-ceo-exit-20240328-p5ffvf